FARP1-AS1

Across TCGA pan-cancer cohorts, FARP1-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FARP1-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher FARP1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FARP1-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO and GBM show a favorable association.

ACC, MESO, and KIRC are the cancer types where FARP1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.406	0.746	<.001	110	view →
MESO	DFS	Quartile	II,III,IV	0.568	0.301	.001	52	view →
KIRC	DFS	Quartile	All	0.632	0.870	.001	38	view →
KICH	OS	Quartile	III,IV	0.194	0.723	.013	34	view →
GBM	DFS	Tertile	All	0.357	0.195	.002	30	view →
LIHC	OS	Tertile	All	0.347	0.625	.004	29	view →
OV	OS	Median	IV	0.477	0.774	.003	28	view →
SARC	DFS	Quartile	All	0.418	0.725	.001	19	view →
CHOL	OS	Quartile	All	1.000	0.557	.009	19	view →
LGG	DFS	Quartile	All	0.743	0.857	.001	19	view →
READ	DFS	Tertile	All	0.552	0.831	.004	15	view →
PRAD	DFS	Tertile	All	0.629	0.908	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

FARP1-AS1–ACC (DFS)

Open the ACC breakdown →